her1 Raises €5.5M in Series A Funding

Chanyu Xu, CEO, and Rita Ugwu, Chief Medical Officer
Chanyu Xu, CEO, and Rita Ugwu, Chief Medical Officer

her1, a Berlin, Germany-based female wellness brand, raised €5.5M in Series A funding.

The round was led by Five Seasons Ventures with participation from previous seed investors Rheingau Founders and IBB Ventures.

The company intends to use the funds to grow in the European market, develop new products for different life stages, and expand its finance, marketing and product teams.

Founded in 2017 by serial FoodTech entrepreneur Chanyu Xu, CEO, and also led by Rita Ugwu, Chief Medical Officer, her1 is a direct-to-consumer company that provides natural and plant-based products to boost gut health and aid women’s health and beauty from within.
The company launched its flagship product, Inner Beauty, in 2019 after over a year of research and development. The product contains over 25 billion active, natural and good microorganisms per daily serving, to support a healthy microbiome. 

her1 develops all its own products, using natural, plant-based, gluten and sugar-free blends made from locally sourced whole foods and containing prebiotics and probiotics to feed the gut microbiome. In addition to powders and supplements, the company offers care packages and provides accessories. Most recently, her1 launched Gut One, a daily supplement to help the gut-brain-axis with probiotics and essential b-vitamins for optimal brain and cognitive functioning, which is also available on subscription. 

FinSMEs

21/07/2021